CTRI/2024/02/063048尚未招募4 期
A Prescription Event Monitoring (PEM) Study to Evaluate the Effects of Adjuvant Therapy with ZincorespTM Syrup in Children Aged 2- 12 Years Having Recurrent Respiratory Disorders and Infections. - NA
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Children between 2-12 years of age of any gender.
- •2. Children having recurrent episodes of any of the following:
- •- Fever associated with respiratory tract infections (RTI)
- •- URTI (rhinitis, pharyngitis, laryngitis, otitis media, influenza)
- •- LRTI (pneumonia, bronchitis, and bronchiolitis)
- •- Bronchial asthma
- •- SARS-CoV-2
- •- Combined allergic rhinitis and asthma syndrome (CARAS)
- •- Pulmonary tuberculosis
- •3.Parents are willing to give consent for the child’s participation in study.
排除标准
- •1. Any evidence of malignancy.
- •2. History and clinical findings suggestive of metabolic diseases
- •3. History and clinical findings suggest chronic respiratory tract diseases including interstitial lung disease (ILD) and cystic fibrosis.
- •4. History of respiratory tract surgery.
- •5. Known diagnosis of congenital cardiac defects.
研究者
相似试验
尚未招募
4 期
The Effects and safety of ZincorespTM Tablets/ Syrup in Patients Having Ear, Nose, Throat and Respiratory Disorders and Infections.CTRI/2024/02/063092apex laboratories private Limited
尚未招募
4 期
The effects of zinccorespTM tablets on patients with infections and respiratory disorders.CTRI/2024/02/063149apex laboratories private limited
尚未招募
4 期
Real world study to evaluate the safety and efficacy of NUWOK tab and Injection in the patients have infection.CTRI/2024/04/065903Wockhardt Ltd
尚未招募
4 期
Prescription event monitoring study of Emrok injection and tabin the patient of diabetes foot ulcer.CTRI/2024/04/065615Wockhardt Ltd
已完成
不适用
Real world data of patients across India will be retrospectively collected in this study of Levonadifloxacin.CTRI/2020/09/028152Wockhardt Limited